Position in ACAD
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$38,380,602
-$2,555,037 QoQ
Shares Held
1,724,196
+12.5% QoQ
Ownership
1.01%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
20 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ACAD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026RENAISSANCE TECHNOLOGIES LLC holds $3,467,670,450 across 330 Biotechnology names. ACAD ranks #16 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
13,726,993 | $588,750,729 | |
| 2 | INCY |
Incyte Corp
|
3,651,532 | $343,682,191 | |
| 3 | CORT |
Corcept Therapeutics Inc
|
5,682,783 | $229,072,982 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
421,688 | $188,300,559 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
819,374 | $154,902,654 | |
| 6 | GMAB |
Genmab A/S
|
4,414,550 | $118,442,376 | |
| 7 | INVA |
Innoviva, Inc.
|
4,055,632 | $94,496,225 | |
| 8 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
1,036,495 | $64,988,236 |
All Filings in ACAD
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $38,380,602 | 1,724,196 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $40,935,639 | 1,532,596 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $30,933,034 | 1,449,533 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $33,384,579 | 1,547,732 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $24,533,518 | 1,477,033 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $22,506,880 | 1,226,533 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $6,201,216 | 403,200 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $7,735,000 | 476,000 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $10,609,562 | 573,800 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $5,761,040 | 184,000 | Shares | Sole | 2024-02-13 | |
| 2023-06-30 | $3,132,660 | 130,800 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $2,216,996 | 117,800 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $5,025,944 | 315,700 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $616,772 | 37,700 | Shares | Sole | 2022-11-14 | |
| 2022-03-31 | $351,190 | 14,500 | Shares | Sole | 2022-05-13 | |
| 2021-03-31 | $14,989,800 | 581,000 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $9,751,104 | 182,400 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $11,116,875 | 269,500 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $5,438,334 | 112,200 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $2,568,800 | 60,800 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||